Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PWSL | ISIN: US74365A3095 | Ticker-Symbol: PBDA
Tradegate
04.11.24
14:05 Uhr
1,169 Euro
+0,020
+1,74 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PROTALIX BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
PROTALIX BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0091,31821:49
1,1421,18521:46

Aktuelle News zur PROTALIX BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.10.Protalix BioTherapeutics, Inc. - 8-K, Current Report4
03.09.Protalix stock jumps 11% on promissory note repayment9
14.08.Protalix BioTherapeutics Inc. Q2 Earnings Summary293JERUSALEM (dpa-AFX) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):Earnings: -$2.20 million in Q2 vs. $19.34 million in the same period last year. EPS: -$0.03...
► Artikel lesen
14.08.Protalix BioTherapeutics, Inc. - 10-Q, Quarterly Report2
14.08.Protalix BioTherapeutics GAAP EPS of -$0.03 misses by $0.05, revenue of $13.47M beats by $0.97M4
14.08.Protalix BioTherapeutics, Inc. - 8-K, Current Report1
14.08.Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results168Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company...
► Artikel lesen
13.08.Protalix BioTherapeutics Q2 Earnings Preview2
01.07.Protalix BioTherapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
11.05.Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript3
10.05.Earnings call: Protalix BioTherapeutics Q1 2024 financial results4
10.05.Protalix BioTherapeutics, Inc. - 10-Q, Quarterly Report1
10.05.Protalix BioTherapeutics Inc. Q1 Loss Increases, Misses Estimates396JERUSALEM (dpa-AFX) - Protalix BioTherapeutics Inc. (PLX) released Loss for its first quarter that increased from last year and missed the Street estimates.The company's earnings came in at...
► Artikel lesen
10.05.Protalix BioTherapeutics GAAP EPS of -$0.06 misses by $0.04, revenue of $3.75M4
10.05.Protalix BioTherapeutics, Inc. - 8-K, Current Report2
10.05.Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results822Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, May 10, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company...
► Artikel lesen
09.05.Protalix BioTherapeutics Q1 Earnings Preview2
14.03.Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results304Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, March 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company...
► Artikel lesen
06.11.23Protalix BioTherapeutics Inc. Q3 loss drops in line with estimates455JERUSALEM (dpa-AFX) - Protalix BioTherapeutics Inc. (PLX) released Loss for third quarter that decreased from the same period last year in line with the Street estimates.The company's bottom...
► Artikel lesen
06.11.23Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results273Company to host conference call and webcast today at 8:30 a.m. EST CARMIEL, Israel, Nov. 6, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1